Alector Inc (Alector) is a biotechnology company that develops therapies for the immune system to cure neurodegeneration and cancer. The company discovers and develops immune-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody technology and recent discoveries in neuroimmunology and oncology to fight cancer. Alector also generates and validates antibody drugs that are into disease-altering and genetically validated neuroimmune targets. The company develops drugs through collaborations with scientists and drug developers. It operates a manufacturing facility in Milpitas, California. Alector is headquartered in South San Francisco, California, the US.
Alector Inc premium industry data and analytics
Products and Services
Services |
---|
Services |
Drug Discovery |
Antibody Drugs Validation |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | Alector Inc | Denali Therapeutics Inc | Allele Biotechnology and Pharmaceuticals Inc | AZTherapies Inc | Caraway Therapeutics Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | South San Francisco | South San Francisco | San Diego | Boston | Cambridge |
State/Province | California | California | California | Massachusetts | Massachusetts |
No. of Employees | 244 | 445 | - | - | - |
Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Tillman Gerngross | Chairman | Executive Board | 2013 | 59 |
Arnon Rosenthal | Director; Chief Executive Officer | Executive Board | 2013 | 68 |
Marc Grasso | Chief Financial Officer | Senior Management | 2022 | 50 |
Clare Hunt | Chief People Officer | Senior Management | - | - |
Gary Romano | Chief Medical Officer | Senior Management | - | 62 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer